05:10 PM EST, 11/18/2024 (MT Newswires) -- GRAIL (GRAL) said Monday the first patient has been tested for eligibility with the company's investigational lung cancer ctDNA blood-based test in a phase 3 trial assessing adjuvant treatment regimens in people with non-small cell lung cancer. The trial, which is sponsored by AstraZeneca ( AZN ) in collaboration with Daiichi Sankyo, uses...

05:09 PM EST, 11/18/2024 (MT Newswires) -- Iron Mountain (IRM) purchased two data center development sites in Virginia to bolster capacity by 350 megawatts to 1.2 gigawatts globally. The acquisitions include a 66-acre development site in Richmond with 200 MW of capacity and a 40-acre site in Manassas with 150 MW of capacity, the company said Monday in a statement....

04:45 PM EST, 11/18/2024 (MT Newswires) -- Spyre Therapeutics ( SYRE ) said Monday it started an underwritten public offering of up to $200 million of shares or pre-funded warrants. Underwriters will be given an option for a 30-day period to buy up to an additional $30 million of shares, the company said. All of the shares and warrants will...

05:10 PM EST, 11/18/2024 (MT Newswires) -- (Updates with comment from Henry Schein in the fourth paragraph.) Henry Schein's (HSIC) activist investor Ananym Capital Management is asking the company to revamp its board, consider divesting its medical distribution business, reduce expenses, and replace Chief Executive Stanley Bergman, Reuters reported Monday, citing sources close to the matter. The firm told the...